Pharmagreen Biotech Inc. – OTC:PHBI

Pharmagreen Biotech stock price today

$0.001
-0.00
-47.06%
Financial Health
0
1
2
3
4
5
6
7
8
9

Pharmagreen Biotech stock price monthly change

+100.00%
month

Pharmagreen Biotech stock price quarterly change

+100.00%
quarter

Pharmagreen Biotech stock price yearly change

+233.33%
year

Pharmagreen Biotech key metrics

Market Cap
2.95M
Enterprise value
2.42M
P/E
-2.19
EV/Sales
N/A
EV/EBITDA
-2.61
Price/Sales
N/A
Price/Book
-1.17
PEG ratio
-0.02
EPS
N/A
Revenue
4.05K
EBITDA
-349.67K
Income
-583.78K
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
-8621.15%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Pharmagreen Biotech stock price history

Pharmagreen Biotech stock forecast

Pharmagreen Biotech financial statements

Pharmagreen Biotech Inc. (OTC:PHBI): Profit margin
Mar 2023 963 -204.41K -21226.79%
Jun 2023 597 -162.90K -27287.27%
Sep 2023 1.43K -178.51K -12414.05%
Mar 2024 1.05K -37.95K -3587.43%
Pharmagreen Biotech Inc. (OTC:PHBI): Debt to assets
Mar 2023 162988 2.15M 1319.83%
Jun 2023 140313 2.29M 1633.03%
Sep 2023 121567 2.30M 1894.37%
Mar 2024 103810 2.41M 2323.57%
Pharmagreen Biotech Inc. (OTC:PHBI): Cash Flow
Mar 2023 -34.26K 0 18.84K
Jun 2023 7.51K 0 17.69K
Sep 2023 -27.58K 0 -589
Mar 2024 -26.51K 0 28.03K

Pharmagreen Biotech other data

Insider Compensation
Mr. Terry Kwan B.Com., C.A., CPA (1948) Principal Accounting Officer
$94,980
Mr. Peter Wojcik B.A. (1972) Pres, Chief Executive Officer, Sec., Treasurer & Director
$94,980
  • What's the price of Pharmagreen Biotech stock today?

    One share of Pharmagreen Biotech stock can currently be purchased for approximately $0.

  • When is Pharmagreen Biotech's next earnings date?

    Unfortunately, Pharmagreen Biotech's (PHBI) next earnings date is currently unknown.

  • Does Pharmagreen Biotech pay dividends?

    No, Pharmagreen Biotech does not pay dividends.

  • How much money does Pharmagreen Biotech make?

    Pharmagreen Biotech has a market capitalization of 2.95M.

  • What is Pharmagreen Biotech's stock symbol?

    Pharmagreen Biotech Inc. is traded on the OTC under the ticker symbol "PHBI".

  • What is Pharmagreen Biotech's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.

  • How do i buy shares of Pharmagreen Biotech?

    Shares of Pharmagreen Biotech can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Pharmagreen Biotech's key executives?

    Pharmagreen Biotech's management team includes the following people:

    • Mr. Terry Kwan B.Com., C.A., CPA Principal Accounting Officer(age: 77, pay: $94,980)
    • Mr. Peter Wojcik B.A. Pres, Chief Executive Officer, Sec., Treasurer & Director(age: 53, pay: $94,980)
  • When Pharmagreen Biotech went public?

    Pharmagreen Biotech Inc. is publicly traded company for more then 7 years since IPO on 15 Aug 2018.

  • What is Pharmagreen Biotech's official website?

    The official website for Pharmagreen Biotech is pharmagreen.ca.

  • Where are Pharmagreen Biotech's headquarters?

    Pharmagreen Biotech is headquartered at 2987 Blackbear Court, Coquitlam, BC.

  • How can i contact Pharmagreen Biotech?

    Pharmagreen Biotech's mailing address is 2987 Blackbear Court, Coquitlam, BC and company can be reached via phone at +7 028039404.

Pharmagreen Biotech company profile:

Pharmagreen Biotech Inc.

pharmagreen.ca
Exchange:

OTC

Full time employees:

0

Industry:

Drug Manufacturers—Specialty & Generic

Sector:

Healthcare

Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada.

2987 Blackbear Court
Coquitlam, BC V3E 3A2

CIK: 0001435181
ISIN: US71716C1099
CUSIP: 71716C109